{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:59:34Z","timestamp":1790891974904,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacep.2026.08.020","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:38:03Z","timestamp":1790890683000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-9687","authenticated-orcid":false,"given":"Merve Maze","family":"Aydemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Nalbant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Karacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dclk\u00fc","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclhan","family":"Tunca \u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Demirel Ba\u015fg\u00f6ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serta\u00e7","family":"Haydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Akku\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Han\u00f6z\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Zeki","family":"G\u00fcnl\u00fco\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recep \u015eiyar","family":"Balik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Canda\u015f","family":"Kafali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celal","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakup","family":"Erg\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Tuzcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jacep.2026.08.020_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.hlc.2019.10.013","article-title":"50 years of catecholaminergic polymorphic ventricular tachycardia (CPVT) \u2013 time to explore the dark side of the moon","volume":"29","author":"Pflaumer","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"8","key":"10.1016\/j.jacep.2026.08.020_bib2","first-page":"1104","article-title":"Clinical characteristics, genetic findings and arrhythmic outcomes of patients with catecholaminergic polymorphic ventricular tachycardia from China: a systematic review","volume":"12","author":"Leung","year":"2022","journal-title":"Life (Basel)"},{"issue":"20","key":"10.1016\/j.jacep.2026.08.020_bib3","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.jacc.2020.12.073","article-title":"Precision medicine in catecholaminergic polymorphic ventricular tachycardia","volume":"77","author":"Priori","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"40","key":"10.1016\/j.jacep.2026.08.020_bib4","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jacep.2026.08.020_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","article-title":"An international multicenter cohort study on \u03b2-Blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"145","author":"Peltenburg","year":"2022","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacep.2026.08.020_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia a randomized clinical trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"25","key":"10.1016\/j.jacep.2026.08.020_bib7","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.123.064786","article-title":"Flecainide is associated with a lower incidence of arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"148","author":"Bergeman","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacep.2026.08.020_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry","volume":"8","author":"Roston","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"12","key":"10.1016\/j.jacep.2026.08.020_bib9","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review","volume":"15","author":"Roston","year":"2018","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.jacep.2026.08.020_bib10","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.hrthm.2024.04.006","article-title":"An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"21","author":"Lamba","year":"2024","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.jacep.2026.08.020_bib11","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.jacep.2026.03.027","article-title":"How many CPVT patients need an ICD?: the impact of left cardiac sympathetic denervation","volume":"12","author":"Bos","year":"2026","journal-title":"JACC Clin Electrophysiol"},{"issue":"19","key":"10.1016\/j.jacep.2026.08.020_bib12","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"New Engl J Med"},{"issue":"25","key":"10.1016\/j.jacep.2026.08.020_bib13","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacep.2026.08.020_bib14","first-page":"1","article-title":"Catecholaminergic polymorphic ventricular tachycardia: advancing from molecular insights to preclinical models","volume":"14","author":"Schneider","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.jacep.2026.08.020_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIRCEP.112.973230","article-title":"Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved ejection fraction registry","volume":"5","author":"Krahn","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.jacep.2026.08.020_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jamacardio.2022.0219","article-title":"Outcomes of patients with catecholaminergic polymorphic ventricular tachycardia treated with \u03b2-Blockers","volume":"7","author":"Mazzanti","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.jacep.2026.08.020_bib17","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.84.3.1136","article-title":"The long QT syndrome. Prospective longitudinal study of 328 families","volume":"84","author":"Moss","year":"1991","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacep.2026.08.020_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/europace\/euw389","article-title":"The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry","volume":"20","author":"Roston","year":"2018","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.jacep.2026.08.020_bib19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/0002-9149(76)90420-3","article-title":"Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold","volume":"37","author":"Schwartz","year":"1976","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.jacep.2026.08.020_bib20","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/jcm13061781","article-title":"Catecholaminergic polymorphic ventricular tachycardia: clinical characteristics, diagnostic evaluation and therapeutic strategies","volume":"13","author":"Aggarwal","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jacep.2026.08.020_bib21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacep.2024.10.005","article-title":"International multicenter cohort study on beta-Blocker\u2013Free treatment strategies for catecholaminergic polymorphic ventricular tachycardia patients","volume":"11","author":"Neves","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.jacep.2026.08.020_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00392-012-0492-7","article-title":"Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome","volume":"102","author":"Schneider","year":"2013","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2026.08.020_bib23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/joa3.13069","article-title":"Cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia in the light of the medical situation in Japan","volume":"40","author":"Mori","year":"2024","journal-title":"J Arrhythm"},{"issue":"1","key":"10.1016\/j.jacep.2026.08.020_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13023-023-02991-0","article-title":"Clinical and genetic profiles of Chinese pediatric patients with catecholaminergic polymorphic ventricular tachycardia","volume":"18","author":"Yan","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.jacep.2026.08.020_bib25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jfma.2024.07.021","article-title":"Genetic and clinical characteristics of catecholaminergic polymorphic ventricular tachycardia in a Taiwanese nationwide cohort","volume":"124","author":"Hsu","year":"2025","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"10.1016\/j.jacep.2026.08.020_bib26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.120.045723","article-title":"An international multicenter evaluation of inheritance patterns, arrhythmic risks, and underlying mechanisms of CASQ2 -Catecholaminergic polymorphic ventricular tachycardia","volume":"142","author":"Ng","year":"2020","journal-title":"Circulation"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26008418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26008418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:38:06Z","timestamp":1790890686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X26008418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":26,"alternative-id":["S2405500X26008418"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2026.08.020","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2026.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}